Abstract:The antagonism, stalemate and compromise between the immune system and tumor cells is closely associated with tumor development and progression. In recent years, tumor immunotherapy has made continuous breakthroughs. It has become an important approach for cancer treatment, improving the survival and prognosis of more and more tumor patients. Further investigating the mechanism of tumor immune regulation, and exploring tumor immunotherapy targets with high specificity and wide applicability will provide researchers and clinicians with favorable weapons towards cancer. Ubiquitination affects protein fate through influencing the activity, stability and location of target protein. The regulation of substrate protein fate by ubiquitination is involved in cell cycle, apoptosis, transcriptional regulation, DNA repair, immune response, protein degradation and quality control. E3 ubiquitin ligase selectively recruits specific protein substrates through specific protein-protein interactions to determine the specificity of the overall ubiquitin modification reaction. Immune-checkpoint inhibitory pathway is an important mechanism for tumor cells to evade immune killing, which can inhibit T cell activity. Blocking the immune checkpoints and activating T cells through targeting the negative regulatory factors of T cell activation and removing the "brake" of T lymphocytes can enhance T cells immune response against tumors. Therefore, blocking the immune checkpoint is one of the methods to enhance the activity of T cells, and it is also a hot target for the development of anti-tumor drugs in recent years, whose inhibitors have shown good effect in specific tumor treatment. Ubiquitination, as one of the most important post-translational modification of proteins, also modulates the expression, intracellular trafficking, subcellular and membranous location of immune checkpoints, regulating the immune surveillance of T cells to tumors.

Immune regulation by ubiquitin conjugation.

Ubiquitin ligases and the immune response.

Immunity by Ubiquitylation: a Reversible Process of Modification

The ubiquitin system in immune regulation.

Immune regulation by protein ubiquitination: roles of the E3 ligases VHL and Itch

Advance in Research on the Regulation of Innate Immune Response by Ubiquitination

Immune Regulation by Ubiquitin Tagging As Checkpoint Code.

Ubiquitin Signaling in Immune Responses

Targeted Modulation of E3 Ligases Using Engineered Ubiquitin Variants.

The Ubiquitylation System: Targeting Proteins for Degradation and Beyond

The Role of Ubiquitination in Regulation of Innate Immune Signaling.

Ubiquitination Enzymes

Getting into position: the catalytic mechanisms of protein ubiquitylation

Ubiquitin ligase enzymes and de-ubiquitinating enzymes regulate innate immunity in the TLR, NLR, RLR, and cGAS-STING pathways

Progress in Structural and Functional Study of Ubiquitin Ligases

A General Strategy for Discovery of Inhibitors and Activators of RING and U-box E3 Ligases with Ubiquitin Variants

Regulation of Innate Antiviral Immunity by Protein Ubiquitination

Ubiquitination of Immune System and Cancer Therapy

Targeting the ubiquitination/deubiquitination process to regulate immune checkpoint pathways

Emerging roles of Lys63‐linked polyubiquitylation in immune responses

Regulation of Cancer Immune Checkpoint: Mono- and Poly-Ubiquitination: Tags for Fate